A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Intervent

Sponsor
University of Colorado, Denver (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05231421
Collaborator
American Cancer Society, Inc. (Other)
20
1
36
0.6

Study Details

Study Description

Brief Summary

This research intends to identify common smoking triggers and barriers to quitting smoking; understand useful and effective strategies for smoking cessation; and explore the feasibility and acceptability of mobile phone-based interventions among low-income smokers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Focus Group

Detailed Description

This research intends to identify common smoking triggers and barriers to quitting smoking; understand useful and effective strategies for smoking cessation; and explore the feasibility and acceptability of mobile phone-based interventions among low-income smokers.

Specific research questions of this research project are:
  1. What are the common smoking triggers and barriers to quitting smoking for low-income smokers?

  2. What are the preferred and useful smoking cessation strategies based on low-income smokers quitting experience?

  3. What is the feasibility and acceptability of using a) text messages, b) virtual reality programs, and c) just-in-time adaptive smoking cessation interventions among low-income smokers?

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Interventions (JITAI) for Smoking Cessation Among Low-income Smokers
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Low-income smokers

Interested participants will first complete a screening survey asking about their demographic information and checking whether are eligible for this study. If eligible, participants will read a consent statement. Only those who give consent would be allowed to proceed. If participants agree to be in this study, they will continue to participate in the study and schedule a time for focus group discussion.

Behavioral: Focus Group
Each focus group will consist of 5-10 participants. They will first introduce to each other and be asked to keep information shared during the session private. The moderator will initiate some questions for the group to discuss. Prompt and follow-up questions will be asked. There is no right or wrong answer for each question and no sensitive questions will be asked. The conversations during the focus group discussion will be recorded. The group will be debriefed about the purpose of the study and have a chance to ask any questions about the study if they have. The focus group discussion for each session will last about 60-90 minutes.

Outcome Measures

Primary Outcome Measures

  1. Use focus group discussion to identify barriers faced by low-income smokers [12 months]

    This study intends to identify the barriers faced by low-income smokers to obtaining smoking cessation services/support using focus groups of current smokers.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  1. between 18 and 89 years old

  2. current smokers

  3. reside in Denver Metropolitan Area

  4. have a personal cell phone

  5. have a household income at or lower than 200% of the federal poverty level; and

  6. ability to read and speak English or Spanish (since a large proportion of the low-SES population in Denver are Spanish speakers).

Exclusion criteria:
  1. Unable to provide informed consent;

  2. age ≥ 89 years;

  3. unable to speak or understand English, or Spanish.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Colorado Research Center Aurora Colorado United States 80045

Sponsors and Collaborators

  • University of Colorado, Denver
  • American Cancer Society, Inc.

Investigators

  • Principal Investigator: Shuo Zhou, Colorado Research Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT05231421
Other Study ID Numbers:
  • 19-2555.cc
First Posted:
Feb 9, 2022
Last Update Posted:
Feb 9, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 9, 2022